throbber
IPR2020-01454
`
`U.S. Patent No. 9,125,739
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________
`
`MEDTRONIC COREVALVE LLC,
`
`Petitioner,
`
`v.
`
`COLIBRI HEART VALVE LLC,
`
`Patent Owner.
`
`____________
`
`Case IPR2020-01454
`
`U.S. Patent No. 9,125,739
`
`____________
`
`
`PETITIONER’S REPLY BRIEF IN SUPPORT OF
`PETITION FOR INTER PARTES REVIEW
`
`
`
`

`

`IPR2020-01454
`
`U.S. Patent No. 9,125,739
`
`
`
`Exhibit
`(“Ex.”)
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`1008
`
`1009
`
`1010
`
`1011
`
`1012
`
`1013
`
`1014
`
`1015
`
`1016
`
`1017
`
`1018
`
`LIST OF EXHIBITS
`
`Description
`
`U.S. Patent No. 9,125,739 (“’739”)
`
`Declaration of William J. Drasler, Ph.D. (“Drasler”)
`
`File History of U.S. Patent No. 9,125,739
`
`Reserved
`
`U.S. Patent No. 6,425,916 to Garrison
`
`U.S. Patent No. 5,957,949 to Leonhardt
`
`Reserved
`
`U.S. Patent No. 6,077,295 to Limon
`
`U.S. Patent No. 7,025,780 to Gabbay
`
`International Patent No. WO 00/15147 to Phelps
`
`File History of U.S. Patent 8,900,294
`
`International Patent No. WO 98/29057 to Letac
`
`U.S. Patent No. 5,840,081 to Andersen
`
`Reserved
`
`File History of U.S. Patent Application No. 09/659,882
`
`File History of U.S. Patent Application No. 10/887,688
`
`File History of U.S. Patent Application No. 13/675,665
`
`File History of U.S. Patent Application No. 10/037,266
`
`i
`
`

`

`1019
`
`1020
`
`1021
`
`1022
`
`1023
`
`1024
`
`1025
`
`1026
`
`1027
`
`1028
`
`1029
`
`1030
`
`1031
`
`1032
`
`1033
`
`1034
`
`1035
`
`1036
`
`IPR2020-01454
`
`U.S. Patent No. 9,125,739
`AneuRX Stent Graft System.pdf available at
`https://www.accessdata.fda.gov/cdrh_docs/pdf/P990020c.pdf
`
`U.S. Patent No. 5,961,549 to Nguyen
`
`U.S. Patent No. 5,713,950 to Cox
`
`Screenshot of Docket Navigator Time-to-Milestone Report for the
`United States District Court of the Central District of California
`
`Stipulation Regarding IPRs, dated September 1, 2020
`
`Declaration of Crena Pacheco
`
`Stipulation Regarding IPRs, dated December 22, 2020
`
`Jane Doe et al. v. Xavier Becerra et al., No. 8:19-cv-02105, U.S.
`District Court Docket (C.D. Cal.)
`
`Shuthima Pongsai V. Am. Express Co., No. 8:19cv1628, U.S. District
`Court Docket (C.D. Cal.)
`
`C.D. Cal. General Order 20-12 dated September 14, 2020
`
`C.D. Cal. General Order 20-15 dated November 25, 2020
`
`C.D. Cal. General Order 20-05 dated April 13, 2020
`
`C.D. Cal. General Order 20-08 dated May 28, 2020
`
`C.D. Cal. General Order 20-09 dated August 6, 2020
`
`C.D. Cal. Order of the Chief Judge 20-042 dated March 19, 2020
`
`Activation of Continuity of Operations Plan dated December 7, 2020
`
`Press Release - Activation of Continuity of Operations Plan dated
`December 7, 2020
`
`Colibri Heart Valve LLC v Medtronic Corevalve LLC, No. 8:20-cv-
`00847, U.S. District Court Docket (C.D. Cal.)
`
`1037
`
`Extension of Continuity of Operations Plan dated January 6, 2021
`
`ii
`
`
`

`

`1038
`
`1039
`
`IPR2020-01454
`
`U.S. Patent No. 9,125,739
`Colibri Heart Valve LLC v Medtronic Corevalve LLC, No. 8:20-cv-
`00847-DOC-JDE, Dkt. 73, Scheduling Order (C.D. Cal. November 24,
`2020)
`
`Medtronic, Inc. v. Axonics Modulation Techns., Inc., No. 8:19-cv-
`02115-DOC-JDE, Dkt. 55, Order Granting Defendant’s Motion to Stay
`Litigation Pending Inter Partes Review (C.D. Cal. May 8, 2020)
`
`1040
`
`Declaration of Crena Pacheco
`
`
`
`
`
`
`
`
`iii
`
`
`

`

`IPR2020-01454
`
`U.S. Patent No. 9,125,739
`The Board should not exercise its §314(a) discretion to deny institution. The
`
`Board’s recent precedential decision in Sotera Wireless, Inc. v. Masimo Corp.,
`
`IPR2020-01019, Pap. 12, *14-21 (designated 12/17/2020), Petitioner’s subsequent
`
`stipulation tracking Sotera, Petitioner’s prompt Petition filing 8 months before the
`
`statutory bar, and the court’s recent decisions indefinitely continuing other trial dates
`
`in addition to a 9+ month trial backlog outweigh any factors weighing against
`
`institution. A “holistic review of the Fintiv factors, namely that the timing of the
`
`Petition was reasonable, the relatively limited investment in the parallel proceeding
`
`to date, and that there is minimal potential overlap of the two proceedings, indicates
`
`that the Fintiv factors weigh in favor of instituting inter partes review.” Sotera, *20.
`
`Factor 1: While the district judge indicated during a 11/17/2020 conference
`
`that he intended to deny the motion to stay and that the trial date would not move,
`
`an order has not issued to date and the judge has contemporaneously continued other
`
`trial dates in light of COVID (e.g., Exs. 1026, *16, 1027, *18). Moreover, pandemic
`
`conditions worsened shortly after that status conference. Compare Ex. 1028 (C.D.
`
`Cal. 9/14/2020 Order permitting in-person hearings in emergency civil matters in
`
`district judge’s courthouse), with Ex. 1029 (C.D. Cal. 11/25/2020 Order closing
`
`district judge’s courthouse to public because “local COVID-19 exposure
`
`risks…have increased”), Exs. 1034-1035, 1037 (C.D. Cal. 12/7/2020 Operations
`
`Plan continuing closure/extension). The same judge also granted a similarly-situated
`
`
`
`

`

`IPR2020-01454
`
`U.S. Patent No. 9,125,739
`pre-institution stay motion filed 5 months after the complaint. Ex. 1039, *1-2. Here,
`
`the stay motion was filed 4 months post-complaint. Ex. 1036, *1, 7. Even if the
`
`motion is denied at this stage, the Sotera-stipulation avoids any duplication of efforts.
`
`Factor 2: While the current trial date is 6 months before the expected final
`
`written decision (“FWD”), Petitioner is not aware of any C.D. Cal. trials since
`
`3/23/2020—creating a backlog of 9+ months. Exs. 1028-1035, 1037. The district
`
`and the district judge are continuing to push trial dates out indefinitely—extending
`
`that backlog further. Exs. 1034-1035, 1037, 1026, *16, 1027, *18. PO does not
`
`dispute that the average time to trial for patent cases in the district is 2 years 8 months,
`
`which would result in a 1/2023 trial date (9 months after the FWD) even without the
`
`9+ month backlog due to the pandemic. Ex. 1036, *8. Petitioner is not aware of any
`
`patent case that has previously gone to trial before the district judge. Given the trial
`
`date’s uncertainty, this factor should not weigh for or against exercising discretion.
`
`Regardless, there can be no duplication of efforts due to the Sotera-stipulation.
`
`Factor 3: This factor weighs in favor of not exercising discretionary denial.
`
`The Petition was filed 4 months after the complaint was served (Ex. 1036, *4) and
`
`over 2 months before initial responses to both infringement and invalidity
`
`interrogatories were due. See Snap, Inc. v. SRK Tech. LLC, IPR2020-00820, Pap. 15,
`
`*11 (precedential) (filing promptly after asserted claims are identified favors
`
`institution). While the district court has put the case on a 16-month schedule from
`
`2
`
`
`

`

`IPR2020-01454
`
`U.S. Patent No. 9,125,739
`complaint to trial, that should not outweigh the diligence with which Petitioner has
`
`acted—let alone foreclose Petitioner’s ability to pursue an IPR. Indeed, in Snap and
`
`Sotera, the petitions were filed close to the one-year bar date (id., *12-13; Sotera,
`
`Pap. 12, *17), whereas here the Petition was filed 8 months before the bar date (Ex.
`
`1036, *4 (service 5/5/2020)). PO’s allegations regarding its initial 12/2019
`
`complaint (POPR 21) are irrelevant as it was never served. Even if it had been, the
`
`Petition still would have been over 3 months before the bar date.
`
`Even without further delays, the district court case will be at most only half-
`
`way complete at the time of the institution (3/10/2021)—5 months after the
`
`8/31/2020 Rule 26(f) report and 6 months before trial. Ex. 1036, *7-8. Fact discovery
`
`will close late February, with additional discovery available in the event of a later-
`
`issued Markman order. Ex. 1038, *2-3. In addition, to date, the court has not ruled
`
`on Petitioner’s motion to dismiss and Petitioner has not filed an answer. Ex. 1036.
`
`Factor 4: Given that Petitioner’s stipulation (Ex. 1025) is the same as the
`
`stipulation in Sotera, this factor “weighs strongly in favor of not exercising
`
`discretion to deny institution.” Sotera, Pap. 12, *19. PO’s only case addressing a
`
`similar stipulation applied the wrong weight. IPR2020-00718, Pap. 12, *11 (“weighs
`
`slightly in favor of not exercising…discretion”); see id. *13 (dissenting). Petitioner
`
`stipulated that it will not raise any grounds that it raised or reasonably could have
`
`raised in this IPR in district court if the IPR is instituted. Ex. 1025. The stipulation
`
`3
`
`
`

`

`IPR2020-01454
`
`U.S. Patent No. 9,125,739
`“mitigates any concerns of duplicative efforts between the district court and the
`
`Board, as well as concerns of potentially conflicting decisions.” Sotera, *19.
`
`Factor 6: Petitioner’s trial grounds are especially strong—going well beyond
`
`the required “reasonable likelihood” showing—and each of PO’s §314(a) merits-
`
`based arguments (POPR 27-28) fails. Valve means residing entirely within stent
`
`member’s inner channel when collapsed: Grounds 1, 3: While PO’s strawman
`
`arguments wrongly focus on Garrison’s inverted-delivery embodiment (Figs. 31-38),
`
`the trial grounds instead rely on Garrison’s separate embodiment in Figs. 8-11,
`
`which readily meets the limitation under both of Garrison’s alternative teachings:
`
`where the support structure’s ends have the same “trumpet-like” “features” as the
`
`valve displacer or when “integrated” with the valve displacer. Pet. 29, 35, 42-43.
`
`Each alternative changes the support structure’s shape—not the valve’s location in
`
`its inner channel. Id. Grounds 2, 4: PO’s strawman arguments again mischaracterize
`
`the trial grounds, which rely on Leonhardt’s teaching that the valve is always within
`
`its stent (regardless of whether collapsed or expanded)—advantageously protecting
`
`the valve at each of these stages, including from the trocar and sheath discussed by
`
`PO. Pet. 47-52. Prosthetic heart valve’s distal end is located at the sheath’s distal
`
`end: Grounds 1-10: PO’s arguments that the valve and not the stent must be located
`
`at sheath’s distal end mischaracterize claim 1. POPR 50 (“Petitioner…mislabeled
`
`the entire stent as the valve”), 52, 59-61 (distinguishing Limon and Anderson’s
`
`4
`
`
`

`

`IPR2020-01454
`
`U.S. Patent No. 9,125,739
`valves/stents). Claim 1 instead recites that the stent is part of the prosthetic heart
`
`valve (“a prosthetic heart valve including: a stent member…”) and thus the stent can
`
`satisfy the limitation. Pet. 40-42, 69-71. Stent including tubular structure away
`
`from central portion flares at both ends in a trumpet-like configuration:
`
`Grounds 1-4, 6-7, 9-10: PO’s argument that the stent’s ends cannot be formed of
`
`individual “fingers” or “points,” but instead must be flat like a trumpet (POPR 62-
`
`65) is unsupported by the intrinsic evidence, which only depicts stent ends formed
`
`by individual fingers/points, and belied by PO’s infringement contentions—the
`
`accused device’s ends are formed of such fingers/points. Compare Garrison Fig. 9;
`
`Leonhardt Figs. 1-4; Phelps Figs. 7-8; ’739 Fig. 8; Ex. 2001 (complaint), 9.
`
`Motivation to apply Limon’s teachings to Andersen: Grounds 5-10: PO’s
`
`strawman arguments regarding the application of heat to conform attachment
`
`projections to a stent (POPR 54-55) fail to address the trial grounds’ reliance on
`
`Limon’s alternative teachings of attachment projections that are “soft by design”—
`
`enabling the projections to protect the stented valve and aid in pushing it out (Pet.
`
`56-57, 68). And under the Petition’s alternative showing that does not rely on such
`
`projections (Pet. 56), Limon’s pusher functionality mirrors the ’739’s, which also
`
`does not have a mechanism beyond the catheter to push the valve out—contrary to
`
`PO’s baseless assertion that the ’739’s pusher member has “a larger circumference
`
`than the stented valve on the proximal end” (POPR 55).
`
`5
`
`
`

`

`Dated: January 8, 2021
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2020-01454
`
`U.S. Patent No. 9,125,739
`Respectfully submitted,
`
`
`By: /James L. Davis, Jr./
`
`James L. Davis, Jr.
`Reg. No. 57,325
`ROPES & GRAY LLP
`1900 University Avenue, 6th Floor
`East Palo Alto, CA 94303-2284
`P: 650-617-4794 / F: 617-235-9492
`james.l.davis@ropesgray.com
`
`Counsel for Petitioner
`MEDTRONIC COREVALVE LLC
`
`6
`
`
`

`

`IPR2020-01454
`
`U.S. Patent No. 9,125,739
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that the foregoing PETITIONER’S REPLY BRIEF
`
`IN SUPPORT OF PETITION FOR INTER PARTES REVIEW was served in its
`
`entirety by filing through the Patent Trial and Appeal Board End to End (PTAB E2E),
`
`as well as providing a courtesy copy via e-mail to the following attorneys of record
`
`for Patent Owner listed below:
`
`Lead Counsel
`Sarah E. Spires
`Registration No: 61,501
`SKIERMONT DERBY LLP
`1601 Elm Street, Suite 4400
`Dallas, Texas 75201
`Tel: (214) 978-6600
`Fax: (214) 978-6601
`sspires@skiermontderby.com
`
`
`
`Counsel for Patent Owner Colibri Heart Valve LLC
`
`
`
`Dated: January 8, 2021
`
`Back-up Counsel
`Paul J. Skiermont
`Pro Hac Vice
`SKIERMONT DERBY LLP
`1601 Elm Street, Suite 4400
`Dallas, Texas 75201
`Tel: (214) 978-6600
`Fax: (214) 978-6601
`pskiermont@skiermontderby.com
`
`
`By: /Crena Pacheco/
`Name: Crena Pacheco
`ROPES & GRAY LLP
`
`
`
`
`
`
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket